Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States

Background/Objectives: This retrospective cohort study evaluated the relative vaccine effectiveness (rVE) of two bivalent (original/Omicron BA.4/BA.5) vaccines mRNA-1273.222 versus the BNT162b2 Bivalent in preventing COVID-19-related outcomes in adults with underlying medical conditions associated w...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hagit Kopel, Van Hung Nguyen, Alina Bogdanov, Isabelle Winer, Catherine Boileau, Thierry Ducruet, Ni Zeng, Jessamine P. Winer-Jones, Daina B. Esposito, Mary Bausch-Jurken, Ekkehard Beck, Machaon Bonafede, James A. Mansi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2024-09-01
Ráidu:	Vaccines
Fáttát:	COVID-19 vaccine mRNA-1273 BNT162b2 high risk comorbidities
Liŋkkat:	https://www.mdpi.com/2076-393X/12/10/1107
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!